Cutaneous squamous cell carcinoma (cSCC) is one of the most common skin cancers and leading to death in 0.5 to 2% of the cases in Europe (1) (2) (3) . Numerous pathways are reported to be involved in its development, but the influence of microRNAs (miRNA) has only been sporadically analysed (4) (5) (6) (7) and the relation between their expression and cSCC development has only scarcely been looked at (8, 9) .
We hypothesized that miRNAs are differentially expressed in cSCC and hence influence its development. We therefore isolated total RNA of 10 formalin-fixed and paraffin-embedded (FFPE) well-differentiated cSCCs from 9 immunocompetent individuals without inherited cancer predisposition. Additionally, a HPV analysis was performed (suppl. material). As a control, 11 total RNA samples were isolated from healthy epidermis from patients without SCC. The selected 12 miRNAs (Table S1) were previously reported to be differentially expressed in several types of cancer or are involved in epidermis differentiation (10) (11) (12) . Normalization of miRNA expression was carried out against four different snoRNAs (U18, U24, U44, and U48) reported to be invariably expressed in skin (13) . The study was approved by the local Ethics Committee of Basel and performed according to the declaration of Helsinki.
Expression analyses showed three significantly differentially expressed miRNAs (miR-21, miR-31, miR-205), which were all upregulated in cSCCs (Fig. S1 ). The normalization showed significant results for miR-21 and -31 against all four snoRNAs whereas data for miR-205 was significant only relative to three snoRNAs (Fig. S2 ).
Three miRNAs (miR-17-5p, 106a, -155) were significantly increased only when normalized against some snoRNAs (Fig. S3) . A significant decrease was found in let-7b-5p when normalized against U44. Two miRNAs (miR-184 and -206) were detectable neither in the control skin nor in the cSCCs within a reliable cycle number of less than 40 cycles. HPV-DNA was not detectable in any cSCC sample.
The oncogenic potential of miR-21 is well known and reported in many other cancers (14) . The high induction of miR-21 in the well-differentiated cSCCs vs. normal skin confirms previously published data (8) . Concurrent with our examinations an upregulation of miR-31 in cSCCs was reported (Table 1) (9). Like miR-21, miR-31 is a proto-oncogene (15), but its effect seems to be versatile in several cancers and cancer stages (16) (17) (18) (19) (20) . In cSCC the function of miR-31 has yet to be clarified.
In contrast to previously published data on cSCCs the expression of miR-205 is increased in our samples when normalized to three snoRNAs (U18, U24, and U48) ( Table 1 , Fig S1) (8, 9) . These different results may also be influenced by the method and normalization. Increased levels of miR-205 were shown in aggressive oral SCCs (21) . Supporting a proto-oncogene function, miR-205 enhances the migration of keratinocytes in the cutaneous epidermis (22) . Previous findings revealed that miR-205 is antagonized by miR-184 (21) which is in accordance with our results of an undetectable miRNA-184 level. Previous reports on the expression of miR-184 diverge (8, 9) .
Our analyses showed no difference in the expression of miR-203 in cSCC and in normal skin, as also reported by Xu et al. 2012 . In contrast, Dziunycz et al. 2010 reported this same miRNA to be downregulated in cSCC.
The tumour-suppressor miR-203, a skin and keratinocytes-specific miRNA, mediates p63 degradation (11, (23) (24) (25) . This is in agreement with a decreasing expression of miR-203 with lower differentiation stage of the tumour (8). As we aimed for examination of early and clearly well-differentiated cSCC and found no regulation of miR-203 expression, the miR-203 level could be an indicator for the differentiation grade of the tumour.
Consistently, the expression of miR-34a, another tumour-suppressor downstream of p63, is not differentially regulated in our cSCC tissues.
As reported previously and confirmed by our results, the choice of normalization genes has a strong impact on the results. The results show a clear involvement of several unsuspected miRNAs in cSCC development. As it is known for other cancers, we assume that the miR-levels change during carcinogenesis. This hypothesis could be tested by analysing actinic keratoses and all stages of cSCC. An expression signature of miRNA in different cSCCs could sharpen the individual prognosis of the metastatic risk. Finally, deeper understandig of differential miRNA expression in cSCC development may lead to the development of new and better targeted therapies (19) . HPV is supposedly a risk factor for cSCC development. However, only half of cSCCs reveal HPV-DNA (6, 26, 27) whereas no HPV-activity could be detected (28) . Evidences show that HPV effects are boosted during actinic keratosis (29).
In conclusion, our results reveal new miRNA players in the carcinogenesis of cSCCs. Concurrent with Xu et al.
we identified a significant upregulation of the miR-31 in well differentiated cSCCs. Furthermore we showed the differential upregulation of miRNA-205. Whether miR-205 has an influence on the development of cSCCs must be clarified in subsequent studies. Significant increase of miR-21 in cSCC tissues could be confirmed by our observations. The question on which miRNAs are characteristically differentially expressed during cSCC development remains. For example, miR-21 is generally upregulated in proliferating tissues and miR-125a is downregulated in cutaneous non-tumourous proliferating tissues (30) . In contrast, miR-205 induces keratinocyte migration (22) hence its expression level could be used as a specific marker for cSCCs development. Whether miR-31 upregulation is specific for cSCCs, for other types of SCCs or for other cancers has yet to be determined in additional studies. Data of all stages from precancerous lesion to metastasize cSCC along with the clinical phenotype are essential to achieve a better understanding of the carcinogenesis and aggressiveness of cSCC.
Our experiments reveal that some miRNAs, whose expression is described to be different in cSCCs by several authors, are possible key players in this cancer type and detectable by various methods. Uniform conditions could help to assess the relevance of miRNAs whose expression is differentially described. However, the clarification of the specific miRNA expression in different cSCCs could provide key information to understand the evolution of cSCCs and will ultimately enable us to develop novel potential for treatment of these cancers.
Author contributions:
Christelle Bruegger performed research and prepared the manuscript; Iris Spoerri performed research; Werner Kempf did the HPV analyses; Andreas Arnold surveyed the cSCCs; Peter Itin designed the study and contributed to data analysis; Bettina Burger designed the study, analysed the data and contributed to the manuscript preparation.
Conflict of interest: None
Funding sources: None identified the U44 to be not valuable for normalization. Results also showed significant upregulation for the three miRNAs, whereby the high SD points to the variability of the cSCCs. 
